Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-03 21:54:23 UTC |
---|
Update Date | 2014-12-24 20:25:33 UTC |
---|
Accession Number | T3D2474 |
---|
Identification |
---|
Common Name | Naftidrofuryl |
---|
Class | Small Molecule |
---|
Description | Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. It may also be a 5-HT2 receptor antagonist (2). |
---|
Compound Type | - Amine
- Drug
- Ester
- Ether
- Organic Compound
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | Drosunal | Dubimax | Dusodril | Gevatran | Iridus | Nafronyl | Nafronyl oxalate | Nafronyl oxalate(usan) | Nafronyloxalate | Naftidrofurilo | Naftidrofuryl oxalate | Naftidrofurylum | Naftifurin oxalate | Naphtidrofuryl | Praxilene | Tridus |
|
---|
Chemical Formula | C24H33NO3 |
---|
Average Molecular Mass | 383.524 g/mol |
---|
Monoisotopic Mass | 383.246 g/mol |
---|
CAS Registry Number | 31329-57-4 |
---|
IUPAC Name | 2-(diethylamino)ethyl 3-(naphthalen-1-yl)-2-(oxolan-2-ylmethyl)propanoate |
---|
Traditional Name | naftidrofuryl |
---|
SMILES | CCN(CC)CCOC(=O)C(CC1CCCO1)CC1=C2C=CC=CC2=CC=C1 |
---|
InChI Identifier | InChI=1S/C24H33NO3/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3 |
---|
InChI Key | InChIKey=KBAFPSLPKGSANY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as naphthalenes. Naphthalenes are compounds containing a naphthalene moiety, which consists of two fused benzene rings. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Naphthalenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Naphthalenes |
---|
Alternative Parents | |
---|
Substituents | - Naphthalene
- Fatty acid ester
- Fatty acyl
- Tetrahydrofuran
- Amino acid or derivatives
- Carboxylic acid ester
- Tertiary amine
- Tertiary aliphatic amine
- Carboxylic acid derivative
- Dialkyl ether
- Ether
- Monocarboxylic acid or derivatives
- Oxacycle
- Organoheterocyclic compound
- Carbonyl group
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Amine
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | 190°C at 5.00E-01 mm Hg | Solubility | Not Available | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9120000000-58acd41b3b73264d3617 | 2021-09-24 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0f89-2549000000-3701aef880e3113e8174 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0udr-9822000000-8205fc5c8916c186cad3 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0v6r-8920000000-7c3b1ec379dfac422f84 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-3059000000-dabb68bdf42dd117b1b6 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001r-6295000000-6891e2b71701c4e8a67c | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00dr-9340000000-468b51b4371edaf437a2 | 2016-08-03 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-000i-9100000000-d75c1dd41b1e807c5df5 | 2014-09-20 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral (1). |
---|
Mechanism of Toxicity | Naftidrofuryl blocks the type 2 serotonin (5-HT2) receptors and thereby inhibits the effects of serotonin-induced vasoconstriction
or platelet aggregation. It is also a stimulator of metabolism by improving aerobic glucose metabolism and by these means preserving cell function in ischemic conditions. Overdosage may result in disturbance of the atrioventricular conduction
time, ventricular arrhythmia, convulsions, acute renal failure or acute hepatic necrosis (1). |
---|
Metabolism | Not Available |
---|
Toxicity Values | LD50: 1890 mg/kg (Oral, Rat) (4) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Naftidrofuryl is a drug used in the management of peripheral and cerebral vascular disorders (2). |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Naftidrofuryl increases the peripheric circulation of blood, e.g. in peripheral vascular disease (PAOD), Raynaud's phenomenon, cerebrovascular diseases, diffuse circulatory insufficiency in the elderly going along with confusion or behavioral disturbances. Overdosage may result in disturbance of the atrioventricular conduction time, ventricular arrhythmia, convulsions, acute renal failure or acute hepatic necrosis (1). |
---|
Symptoms | Convulsions, Nausea and epigastric pain, rash, hepatitis or hepatic failure, calcium oxalate stones (1, 3). |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 4417 |
---|
ChEMBL ID | CHEMBL1620794 |
---|
ChemSpider ID | 4264 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | Not Available |
---|
BioCyc ID | TETRA-H-BIOPTERIN |
---|
CTD ID | D009257 |
---|
Stitch ID | Naftidrofuryl |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | - Koller MF, Schmid M, Iten PX, Vonlanthen B, Bar W: Fatal intoxication with naftidrofuryl. Leg Med (Tokyo). 2009 Sep;11(5):229-33. doi: 10.1016/j.legalmed.2009.04.003. Epub 2009 Jun 10. [19520596 ]
- Wikipedia. Naftidrofuryl. Last Updated 16 July 2009. [Link]
- MIMS Hong Kong (2009). Drug Info: Naftidrofuryl. [Link]
- Lookchem (2008). Naftidrofuryl. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|